acute coronary syndrome

Advertisement
Patrick DalyAtrial Fibrillation | April 7, 2023
Antithrombotic therapy with oral anticoagulants (OACs) was associated with reduced risk of ischemic events without ...
Read More
DocWire News EditorsAtrial Fibrillation | April 7, 2023
A team of researchers, led by Jean Jacques Noubiap, aimed to evaluate the incidence, risk factors, and prognosis of ...
DocWire News EditorsAtherosclerotic Disease | April 11, 2023
A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ...
DocWire News EditorsTCT 2020 | April 23, 2023
The use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) improves the accuracy of ...
DocWire News EditorsInterventional Cardiology | June 28, 2023
In patients with a coronary artery bypass graft (CABG) procedure prior to an acute coronary syndrome, alirocumab added ...
Kaitlyn D’OnofrioOncology | September 22, 2023
Roche’s Rozlytrek (entrectinib) has been priced at about half the cost of its competitor, Vitrakvi (larotrectinib), ...
Rob DillardCardiology | July 26, 2019
There exists a link between cancer and takotsubo syndrome (TTS) also known as broken heart syndrome, according to a ...
DocWire News EditorsCardiology | May 15, 2023
This week's edition features a look at research on the IMPROVE-IT population and a potential benefit for elderly ...
DocWire News EditorsCardiology | April 11, 2023
A new analysis suggests that elderly patients may benefit from a high-intensity simvastatin-ezetimibe combination after ...
DocWire News EditorsCardiology | April 11, 2023
This week's edition has some news for those who take nutritional supplements to prevent cardiovascular outcomes, a vote ...
DocWire News EditorsLipid Management | May 2, 2023
A recent analysis of the results of the ODYSSEY OUTCOMES trail suggests that the PCSK9 inhibitor alirocumab added to ...
DocWire News EditorsMedical Devices | April 11, 2023
The digitally supported self-management and self-detection of symptom onset for coronary artery occlusion is feasible, ...
DocWire News EditorsACC 2019 Conference | July 14, 2023
The combination of apixaban and clopidogrel was associated with a reduced risk for bleeding and hospitalization in ...
DocWire News EditorsACC 2019 Conference | April 11, 2023
Depression screening in survivors of acute coronary syndromes (ACS) had no impact on quality of life, according to study ...
DocWire News EditorsCardiology | April 23, 2023
Patients on the extreme end of the coronary artery disease spectrum, like those with recurring acute coronary syndrome ...
DocWire News EditorsCardiology | April 11, 2023
High-sensitivity C-reactive protein (hsCRP) levels were associated with increased risk for suffering averse cardiac ...
DocWire News EditorsLipid Management | May 2, 2023
The cholesterol-lowering PCSK9 inhibitor alirocumab reduced the risk for a second heart in patients who had survived ...
DocWire News EditorsTCT 2018 | September 6, 2023
A polymer-coated zotarolimus-eluting stent (Resolute Onyx) with a novel thin-strut metallic platform demonstrated ...
DocWire News EditorsLipid Management | May 2, 2023
The high-density lipoprotein (HDL) mimetic MDCO-216 does not cause plaque regression in statin-treated acute ...
DocWire News EditorsACC 2018 Conference | September 11, 2023
Patients younger than 75 years of age who suffered an MI and were given ticagrelor did not see an increased risk for ...
Advertisement
Advertisement
Advertisement
Latest News

November 9, 2024